[an error occurred while processing this directive] ����Ƥ���Բ�ѧ��־ 2006, 32(5) 294-296 DOI:     ISSN: 2096-5540 CN: 32-1880/R

����Ŀ¼ | ����Ŀ¼ | ������� | �߼�����                                                            [��ӡ��ҳ]   [�ر�]
����
��չ����
������Ϣ
Supporting info
PDFȫ��
[HTMLȫ��]
�����
�����뷴��
�ѱ����Ƽ�������
�����ҵ����
�������ù�����
����
Email Alert
���·���
���������Ϣ
���Ĺؼ����������
Ƥ��֬Ĥ����Tϸ���ܰ���
����
Ԥ��
���������������
����
������
PubMed
Article by HU Wei-wei
Article by LAO Li-min

Ƥ��֬Ĥ����Tϸ���ܰ����о���չ

����, ������

�㽭��ѧҽѧԺ������ԺƤ����, ����310009

ժҪ��

Ƥ��֬Ĥ����Tϸ���ܰ����ǽ�������ʶ���ټ���Ƥ��Tϸ���ܰ���,��Դ�ڦ���TCRTϸ����æ�TCRTϸ����ϸ������Tϸ����Ƥ��֬Ĥ����Tϸ���ܰ�����Ҫ����ΪƤ�¶෢�Խ�ڡ��߿��Ƥ���׿�,���ֻ��߿ɰ�����Ѫϸ���ۺ���,�����չѸ�١������Ͽɼ�Ƥ��֬Ĥ�����ı�,���пɼ���ϸ��Χ�Ƶ���֬��ϸ���γ������Եġ��������ı䡱,�����黯����Ϊϸ������Tϸ����Դ,������TCR��æ�TCR��������,�Գ��滯�Ʒ�ӦǷ��,Ԥ��ϲ�,��Ԥ���������߱����йء�

�ؼ����� Ƥ��֬Ĥ����Tϸ���ܰ���   ����   Ԥ��  

Subcutaneous Panniculitis-like T Cell Lymphoma:Diagnosis and Management

Department of Dermatology, Second Affiliated Hospital of Zhejiang University, Hangzhou 310009, China

Department of Dermatology, Second Affiliated Hospital of Zhejiang University, Hangzhou 310009, China

Abstract:

Subcutaneous panniculitis-like T cell lymphoma(SPTCL) is a rare type of cutaneous T-cell lymphoma derived from cytotoxic T cells expressing either ���� or �æ�T cell receptors. Clinically, it usually presents with multiple subcutaneous nodules, plaques or masses. Some SPTCL patients may rapidly progress with the complication of hemophagocytic syndrome(HPS). Pathologically, SPTCL shows a subcutaneous panniculitis-like change with characteristic rimming of individual fat cell by tumor cells. Immunohistochemically,it is usually derived from cytotoxic T cells expressing clonal rearrangements of ���� or �æ� T-cell receptor(TCR) gene. SPTCL often poorly responses to routine chemotherapy, and has a poor prognosis, which is associated with the phenotype of SPTCL.

Keywords: Subcutaneous panniculitis-like T cell lymphoma   Therapy   Prognosis  
�ո����� 2006-02-20 �޻�����  ����淢������  
DOI:
������Ŀ:

ͨѶ����: ������,email:laolimin@yahoo.com.cn
���߼��:

�ο����ף�
[1] Gonzalez CL,Medeiros LJ,Braziel RM,et al.T-cell lymphoma involving subcutaneous tissue.A clinicopathologic entity commonly associated with hemophagocytic syndrome.Am J Surg Pathol,1991,15:17-27.
[2] Salhany KE,Macon WR,Choi JK,et al.Subcutaneous panniculitis-like T-cell lymphoma:clinicopathologic,immunophenotypic,and genotypic analysis of alpha/beta and gamma/delta subtypes.Am J Surg Pathol,1998,22:881-893.
[3] Kumar S,Krenacs L,Medeiros J,et al.Subcutaneous panniculitic T-cell lymphoma is a tumor of cytotoxic T lymphocytes.Hum Pathol,1998,29:397-403.
[4] Wang CY,Su WP,Kurtin PJ.Subcutaneous panniculitic T-cell lymphoma.Iht J Dermatol,1996,35:1-8.
[5] Go RS,Wester SM.Immunophenotypic and molecular features,clinical outcomes,treatments,and prognostic factors associated with subcutaneous panniculitis-like T-cell lymphoma:a systematic analysis of 156 patients reported in the literature.Cancer,2004,101:1404-1413.
[6] Munn SE,McGregor JM,Jones A,et al.Clinical and pathological heterogeneity in cutaneous gamma-delta T-cell lymphoma:a report of three cases and a review of the literature.Br J Dermatol,1996,135:976-981.
[7] Ma L,Bandarchi B,Glusac EJ.Fatal subcutaneous panniculitis-like T-cell lymphoma with interface change and dermal mucin,a dead ringer for lupus erythematosus.J Cutan Pathol,2005,32:360-365.
[8] Hoque SR,Child FJ,Whittaker S J,et al.Subcutaneous panniculitis-like T-cell lymphoma:a clinicopathological,immunophenotypic and molecular analysis of six patients.Br J Dermatol,2003,148:516-525.
[9] Przybylski GK,Wu H,Macon WR,et al.Hepatosplenic and subcutaneous panniculitis-like gamma/delta T cell lymphomas are derived from different Vdelta subsets of gamma/delta T lymphocytes.J Mol Diagn,2000,2:11-19.
[10] Mukai HY,Okoshi Y,Shimizu S,et al.Successful treatment of a patient with subcutaneous panniculitis-like T-cell lymphoma with high-dose chemotherapy and total body irradiation.Eur J Haematol,2003,70:413-416.
[11] Go RS,Gazelka H,Hogan JD,et al.Subcutaneous panniculitis-like T-cell lymphoma:complete remission with fludarabine.Ann Hematol,2003,82:247-250.
[12] Ghobrial IM,Weenig RH,Pittlekow MR,et al.Clinical outcome of patients with subcutaneous panniculitis-like T-cell lymphoma.Leuk Lymphoma,2005,46:703-708.
[13] Koizumi K,Sawada K,Nishio M,et al.Effective high-dose chemotherapy followed by autologous peripheral blood stem cell transplantation in a patient with the aggressive form of cytophagic histiocytic panniculitis.Bone Marrow Transplant,1997,20:171-173.
[14] Reimer P,Rudiger T,Muller J,et al.Subcutaneous panniculitis-like T-cell lymphoma during pregnancy with successful autologous stem cell transplantation.Ann Hematol,2003,82:305-309.
�������������

�������� (��ע��:��վʵ�������Ը�, �벻Ҫ������ѧ���޹ص�����!�������ݲ�����վ�۵�.)

Copyright 2008 by ����Ƥ���Բ�ѧ��־